Last reviewed · How we verify

NCT03159247: eyeGuide

The eyeGuide: Improving Glaucoma Self-management With a Personalized Behavior Change Program

Completed NA Last updated 19 March 2024
What this trial tests

NA trial testing eyeGuide in Medication Adherence in 107 participants. Completed in 10 January 2020.

Timeline
12 January 2017
Primary endpoint
10 January 2020
10 January 2020

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposehealth services research
Enrollment107
Start date12 January 2017
Primary completion10 January 2020
Estimated completion10 January 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

40 and older, any sex, with Medication Adherence or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to test the impact of two personalized technology based programs that may help improve adherence to glaucoma medications.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

  1. The Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Pilot Study on Glaucoma Medication Adherence.
    Newman-Casey PA, Niziol LM, Lee PP, Musch DC, et al · · 2020 · cited 33× · PMID 33012330 · DOI 10.1016/j.ogla.2020.04.013
  2. Psychosocial Predictors of Glaucoma Medication Adherence Among the Support, Educate, Empower (SEE) Personalized Glaucoma Coaching Pilot Study Participants.
    Salman M, Andrews C, Heisler M, Darnley-Fisch D, et al · · 2020 · cited 24× · PMID 32087145 · DOI 10.1016/j.ajo.2020.02.009
  3. Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design.
    Newman-Casey PA, Niziol LM, Mackenzie CK, Resnicow K, et al · · 2018 · cited 23× · PMID 30062043 · DOI 10.1186/s40814-018-0320-6
  4. Predicting Adherence With the Glaucoma Treatment Compliance Assessment Tool.
    Sanchez FG, Mansberger SL, Newman-Casey PA. · · 2020 · cited 15× · PMID 32740508 · DOI 10.1097/ijg.0000000000001616
  5. Demographic, Clinical, and Psychosocial Predictors of Change in Medication Adherence in the Support, Educate, Empower Program.
    Miller DJ, Niziol LM, Elam AR, Heisler M, et al · · 2022 · cited 9× · PMID 34098169 · DOI 10.1016/j.ogla.2021.06.001
  6. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.
    Cho J, Niziol LM, Lee PP, Heisler M, et al · · 2022 · cited 6× · PMID 34358735 · DOI 10.1016/j.ogla.2021.07.012
  7. Patient Experience during the Support, Educate, Empower Glaucoma Coaching Program to Improve Medication Adherence: A Pilot Study.
    Hollenhorst CN, Elliott V, Heisler M, Schneider K, et al · · 2020 · cited 4× · PMID 33008556 · DOI 10.1016/j.ogla.2020.04.016
  8. Impact of the Support, Educate, Empower Personalized Glaucoma Coaching Program Pilot Study on Eye Drop Instillation Technique and Self-Efficacy.
    Schneider KJ, Hollenhorst CN, Valicevic AN, Niziol LM, et al · · 2021 · cited 4× · PMID 32781286 · DOI 10.1016/j.ogla.2020.08.003

Verify or expand the search:

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03159247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing